EUR USD GBP
+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Colorectal Cancer - Pipeline Review, H2 2016

  • ID: 4020168
  • Report
  • December 2016
  • 1645 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • 2cureX ApS
  • Bavarian Nordic A/S
  • Eisai Co Ltd
  • Incanthera Ltd
  • Natco Pharma Ltd
  • Redx Pharma Plc
  • MORE
Colorectal Cancer - Pipeline Review, H2 2016

Summary:

The latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer - Pipeline Review, H2 2016, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. Many cases of colon cancer have no symptoms. The following symptoms may indicate colon cancer abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, or other change in bowel habits, narrow stools and weight loss with no known reason. Treatment includes surgery, radiation therapy and chemotherapy.

Report Highlights:

The latest Pharmaceutical and Healthcare latest pipeline guide Colorectal Cancer - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Colorectal Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Colorectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Colorectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 26, 106, 110, 9, 145, 36 and 9 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 15, 8, 22 and 3 molecules, respectively.

Colorectal Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

- The pipeline guide provides a snapshot of the global therapeutic landscape of Colorectal Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Colorectal Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Colorectal Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Colorectal Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Colorectal Cancer (Oncology)

Reasons to Buy:

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Colorectal Cancer (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Colorectal Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 2cureX ApS
  • Bavarian Nordic A/S
  • Eisai Co Ltd
  • Incanthera Ltd
  • Natco Pharma Ltd
  • Redx Pharma Plc
  • MORE
Introduction

Colorectal Cancer Overview

Therapeutics Development

Colorectal Cancer - Therapeutics under Development by Companies

Colorectal Cancer - Therapeutics under Investigation by Universities/Institutes

Colorectal Cancer - Pipeline Products Glance

Colorectal Cancer - Products under Development by Companies

Colorectal Cancer - Products under Investigation by Universities/Institutes

Colorectal Cancer - Companies Involved in Therapeutics Development

Colorectal Cancer - Therapeutics Assessment

Drug Profiles

Colorectal Cancer - Dormant Projects

Colorectal Cancer - Discontinued Products

Colorectal Cancer - Product Development Milestones

Appendix

List of Tables:

Number of Products under Development for Colorectal Cancer, H2 2016

Number of Products under Development for Colorectal Cancer - Comparative Analysis, H2 2016

Number of Products under Development by Companies, H2 2016

Number of Products under Development by Companies, H2 2016 (Contd..1)

Number of Products under Development by Companies, H2 2016 (Contd..2)

Number of Products under Development by Companies, H2 2016 (Contd..3)

Number of Products under Development by Companies, H2 2016 (Contd..4)

Number of Products under Development by Companies, H2 2016 (Contd..5)

Number of Products under Development by Companies, H2 2016 (Contd..6)

Number of Products under Development by Companies, H2 2016 (Contd..7)

Number of Products under Development by Companies, H2 2016 (Contd..8)

Number of Products under Development by Companies, H2 2016 (Contd..9)

Number of Products under Development by Companies, H2 2016 (Contd..10)

Number of Products under Development by Companies, H2 2016 (Contd..11)

Number of Products under Development by Companies, H2 2016 (Contd..12)

Number of Products under Development by Companies, H2 2016 (Contd..13)

Number of Products under Development by Companies, H2 2016 (Contd..14)

Number of Products under Development by Companies, H2 2016 (Contd..15)

Number of Products under Development by Companies, H2 2016 (Contd..16)

Number of Products under Development by Companies, H2 2016 (Contd..17)

Number of Products under Development by Companies, H2 2016 (Contd..18)

Number of Products under Investigation by Universities/Institutes, H2 2016

Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..1)

Comparative Analysis by Late Stage Development, H2 2016

Comparative Analysis by Clinical Stage Development, H2 2016

Comparative Analysis by Early Stage Development, H2 2016

Comparative Analysis by Unknown Stage Development, H2 2016

Products under Development by Companies, H2 2016

Products under Development by Companies, H2 2016 (Contd..1)

Products under Development by Companies, H2 2016 (Contd..2)

Products under Development by Companies, H2 2016 (Contd..3)

Products under Development by Companies, H2 2016 (Contd..4)

Products under Development by Companies, H2 2016 (Contd..5)

Products under Development by Companies, H2 2016 (Contd..6)

Products under Development by Companies, H2 2016 (Contd..7)

Products under Development by Companies, H2 2016 (Contd..8)

Products under Development by Companies, H2 2016 (Contd..9)

Products under Development by Companies, H2 2016 (Contd..10)

Products under Development by Companies, H2 2016 (Contd..11)

Products under Development by Companies, H2 2016 (Contd..12)

Products under Development by Companies, H2 2016 (Contd..13)

Products under Development by Companies, H2 2016 (Contd..14)

Products under Development by Companies, H2 2016 (Contd..15)

Products under Development by Companies, H2 2016 (Contd..16)

Products under Development by Companies, H2 2016 (Contd..17)

Products under Development by Companies, H2 2016 (Contd..18)

Products under Development by Companies, H2 2016 (Contd..19)

Products under Development by Companies, H2 2016 (Contd..20)

Products under Development by Companies, H2 2016 (Contd..21)

Products under Development by Companies, H2 2016 (Contd..22)

Products under Development by Companies, H2 2016 (Contd..23)

Products under Development by Companies, H2 2016 (Contd..24)

Products under Development by Companies, H2 2016 (Contd..25)

Products under Development by Companies, H2 2016 (Contd..26)

Products under Development by Companies, H2 2016 (Contd..27)

Products under Development by Companies, H2 2016 (Contd..28)

Products under Investigation by Universities/Institutes, H2 2016

Products under Investigation by Universities/Institutes, H2 2016 (Contd..1)

Products under Investigation by Universities/Institutes, H2 2016 (Contd..2)

Colorectal Cancer - Pipeline by 2cureX ApS, H2 2016

Colorectal Cancer - Pipeline by 3-V Biosciences Inc, H2 2016

Colorectal Cancer - Pipeline by 3M Drug Delivery Systems, H2 2016

Colorectal Cancer - Pipeline by 3SBio Inc, H2 2016

Colorectal Cancer - Pipeline by 4SC AG, H2 2016

Colorectal Cancer - Pipeline by AB Science SA, H2 2016

Colorectal Cancer - Pipeline by AbbVie Inc, H2 2016

Colorectal Cancer - Pipeline by AbGenomics International Inc, H2 2016

Colorectal Cancer - Pipeline by Accelerated Pharma Inc, H2 2016

Colorectal Cancer - Pipeline by Adamed Sp z oo, H2 2016

Colorectal Cancer - Pipeline by Aduro BioTech Inc, H2 2016

Colorectal Cancer - Pipeline by Advenchen Laboratories LLC, H2 2016

Colorectal Cancer - Pipeline by Alchemia Ltd, H2 2016

Colorectal Cancer - Pipeline by Allinky Biopharma, H2 2016

Colorectal Cancer - Pipeline by Amal Therapeutics SA, H2 2016

Colorectal Cancer - Pipeline by amcure GmbH, H2 2016

Colorectal Cancer - Pipeline by Amgen Inc, H2 2016

Colorectal Cancer - Pipeline by Antibe Therapeutics Inc, H2 2016

Colorectal Cancer - Pipeline by Apac Biotech Pvt Ltd, H2 2016

Colorectal Cancer - Pipeline by Apexigen Inc, H2 2016

Colorectal Cancer - Pipeline by Aphios Corp, H2 2016

Colorectal Cancer - Pipeline by Aposense Ltd, H2 2016

Colorectal Cancer - Pipeline by Arisaph Pharmaceuticals Inc, H2 2016

Colorectal Cancer - Pipeline by ARMO Biosciences Inc, H2 2016

Colorectal Cancer - Pipeline by ArQule Inc, H2 2016

Colorectal Cancer - Pipeline by Array BioPharma Inc, H2 2016

Colorectal Cancer - Pipeline by Asana BioSciences LLC, H2 2016

Colorectal Cancer - Pipeline by Aslan Pharmaceuticals Pte Ltd, H2 2016

Colorectal Cancer - Pipeline by Astellas Pharma Inc, H2 2016

Colorectal Cancer - Pipeline by Astex Pharmaceuticals Inc, H2 2016

Colorectal Cancer - Pipeline by AstraZeneca Plc, H2 2016

Colorectal Cancer - Pipeline by ATLAB Pharma SAS, H2 2016

Colorectal Cancer - Pipeline by AVEO Pharmaceuticals Inc, H2 2016

Colorectal Cancer - Pipeline by B Cell Design SAS, H2 2016

Colorectal Cancer - Pipeline by Basilea Pharmaceutica Ltd, H2 2016

Colorectal Cancer - Pipeline by Bavarian Nordic A/S, H2 2016

Colorectal Cancer - Pipeline by Bayer AG, H2 2016

Colorectal Cancer - Pipeline by BeiGene Ltd, H2 2016

Colorectal Cancer - Pipeline by BeyondSpring Pharmaceuticals Inc, H2 2016

Colorectal Cancer - Pipeline by Biocon Ltd, H2 2016

Colorectal Cancer - Pipeline by Bionomics Ltd, H2 2016

Colorectal Cancer - Pipeline by Bionovis SA, H2 2016

Colorectal Cancer - Pipeline by Biotecnol Ltd, H2 2016

Colorectal Cancer - Pipeline by Biothera Pharmaceutical Inc, H2 2016

Colorectal Cancer - Pipeline by Boehringer Ingelheim GmbH, H2 2016

Colorectal Cancer - Pipeline by Boston Biomedical Inc, H2 2016

Colorectal Cancer - Pipeline by Bristol-Myers Squibb Company, H2 2016

Colorectal Cancer - Pipeline by Burzynski Research Institute Inc, H2 2016

Colorectal Cancer - Pipeline by Calithera Biosciences Inc, H2 2016

Colorectal Cancer - Pipeline by Cancer Prevention Pharmaceuticals Inc, H2 2016

Colorectal Cancer - Pipeline by Carna Biosciences Inc, H2 2016

Colorectal Cancer - Pipeline by Cascadian Therapeutics Inc, H2 2016

Colorectal Cancer - Pipeline by CBT Pharmaceuticals Inc, H2 2016

Colorectal Cancer - Pipeline by CCRP Therapeutics GmbH, H2 2016

Colorectal Cancer - Pipeline by Celgene Corp, H2 2016

Colorectal Cancer - Pipeline by Cellceutix Corp, H2 2016

Colorectal Cancer - Pipeline by Celldex Therapeutics Inc, H2 2016

Colorectal Cancer - Pipeline by Cellectar Biosciences Inc, H2 2016

Colorectal Cancer - Pipeline by Celltrion Inc, H2 2016

Colorectal Cancer - Pipeline by Celyad SA, H2 2016

Colorectal Cancer - Pipeline by Chiome Bioscience Inc, H2 2016

Colorectal Cancer - Pipeline by Chipscreen Biosciences Ltd, H2 2016

Colorectal Cancer - Pipeline by ChoDang Pharm Co Ltd, H2 2016

Colorectal Cancer - Pipeline by Cipla Ltd, H2 2016

Colorectal Cancer - Pipeline by Cleave Biosciences Inc, H2 2016

Colorectal Cancer - Pipeline by Cleveland BioLabs Inc, H2 2016

Colorectal Cancer - Pipeline by COARE Biotechnology Inc, H2 2016

Colorectal Cancer - Pipeline by Coherus BioSciences Inc, H2 2016

Colorectal Cancer - Pipeline by Compugen Ltd, H2 2016

Colorectal Cancer - Pipeline by Cornerstone Pharmaceuticals Inc, H2 2016

Colorectal Cancer - Pipeline by Corvus Pharmaceuticals Inc, H2 2016

Colorectal Cancer - Pipeline by Critical Outcome Technologies Inc, H2 2016

Colorectal Cancer - Pipeline by CrystalGenomics Inc, H2 2016

Colorectal Cancer - Pipeline by Cytune Pharma SAS, H2 2016

Colorectal Cancer - Pipeline by Daiichi Sankyo Company Ltd, H2 2016

Colorectal Cancer - Pipeline by DanDrit Biotech A/S, H2 2016

Colorectal Cancer - Pipeline by Deciphera Pharmaceuticals LLC, H2 2016

Colorectal Cancer - Pipeline by Dicerna Pharmaceuticals Inc, H2 2016

Colorectal Cancer - Pipeline by Double Bond Pharmaceutical International AB, H2 2016

Colorectal Cancer - Pipeline by Dr. Reddy's Laboratories Ltd, H2 2016

Colorectal Cancer - Pipeline by EirGenix Inc, H2 2016

Colorectal Cancer - Pipeline by Eisai Co Ltd, H2 2016

Colorectal Cancer - Pipeline by Eli Lilly and Company, H2 2016

Colorectal Cancer - Pipeline by Endor Nanotechnologies SL, H2 2016

Colorectal Cancer - Pipeline by enGene Inc, H2 2016

Colorectal Cancer - Pipeline by EnGeneIC Ltd, H2 2016

Colorectal Cancer - Pipeline by Ensol Biosciences Inc, H2 2016

Colorectal Cancer - Pipeline by EntreChem SL, H2 2016

Colorectal Cancer - Pipeline by Enzo Biochem Inc, H2 2016

Colorectal Cancer - Pipeline by Etubics Corp, H2 2016

Colorectal Cancer - Pipeline by Exelixis Inc, H2 2016

Colorectal Cancer - Pipeline by F. Hoffmann-La Roche Ltd, H2 2016

Colorectal Cancer - Pipeline by Five Prime Therapeutics Inc, H2 2016

Colorectal Cancer - Pipeline by Formosa Laboratories Inc, H2 2016

Colorectal Cancer - Pipeline by Gene Techno Science Co Ltd, H2 2016

Colorectal Cancer - Pipeline by Genentech Inc, H2 2016

Colorectal Cancer - Pipeline by Genor BioPharma Co Ltd, H2 2016

Colorectal Cancer - Pipeline by Genoscience Pharma, H2 2016

Colorectal Cancer - Pipeline by Genzyme Corp, H2 2016

Colorectal Cancer - Pipeline by Gilead Sciences Inc, H2 2016

Colorectal Cancer - Pipeline by GlaxoSmithKline Plc, H2 2016

Colorectal Cancer - Pipeline by Glycotope GmbH, H2 2016

Colorectal Cancer - Pipeline by Golden Biotechnology Corp, H2 2016

Colorectal Cancer - Pipeline by Green Cross Corp, H2 2016

Colorectal Cancer - Pipeline by Hadasit Medical Research Services & Development Ltd, H2 2016

Colorectal Cancer - Pipeline by Handok Inc, H2 2016

Colorectal Cancer - Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2016

Colorectal Cancer - Pipeline by Heat Biologics Inc, H2 2016

Colorectal Cancer - Pipeline by Hemispherx Biopharma Inc, H2 2016

Colorectal Cancer - Pipeline by Hutchison MediPharma Ltd, H2 2016

Colorectal Cancer - Pipeline by iDD biotech SAS, H2 2016

Colorectal Cancer - Pipeline by Ideaya Biosciences Inc, H2 2016

Colorectal Cancer - Pipeline by Ignyta Inc, H2 2016

Colorectal Cancer - Pipeline by Immodulon Therapeutics Ltd, H2 2016

Colorectal Cancer - Pipeline by ImmuneXcite Inc, H2 2016

Colorectal Cancer - Pipeline by Immunomedics Inc, H2 2016

Colorectal Cancer - Pipeline by Immunovative Therapies Ltd, H2 2016

Colorectal Cancer - Pipeline by Incanthera Ltd, H2 2016

Colorectal Cancer - Pipeline by Incyte Corp, H2 2016

Colorectal Cancer - Pipeline by Innovent Biologics Inc, H2 2016

Colorectal Cancer - Pipeline by Inovio Pharmaceuticals Inc, H2 2016

Colorectal Cancer - Pipeline by Interprotein Corp, H2 2016

Colorectal Cancer - Pipeline by Intezyne Technologies Inc, H2 2016

Colorectal Cancer - Pipeline by Ionis Pharmaceuticals Inc, H2 2016

Colorectal Cancer - Pipeline by IPD Therapeutics BV, H2 2016

Colorectal Cancer - Pipeline by Isofol Medical AB, H2 2016

Colorectal Cancer - Pipeline by Jeil Pharmaceutical Co Ltd, H2 2016

Colorectal Cancer - Pipeline by JHL Biotech Inc, H2 2016

Colorectal Cancer - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2016

Colorectal Cancer - Pipeline by Johnson & Johnson, H2 2016

Colorectal Cancer - Pipeline by KaloBios Pharmaceuticals Inc, H2 2016

Colorectal Cancer - Pipeline by Kancera AB, H2 2016

Colorectal Cancer - Pipeline by Karyopharm Therapeutics Inc, H2 2016

Colorectal Cancer - Pipeline by Kura Oncology Inc, H2 2016

Colorectal Cancer - Pipeline by Laboratorio ELEA SACIF y A, H2 2016

Colorectal Cancer - Pipeline by Lee's Pharmaceutical Holdings Ltd, H2 2016

Colorectal Cancer - Pipeline by Lion Biotechnologies Inc, H2 2016

Colorectal Cancer - Pipeline by LipoMedix Pharmaceutical Inc, H2 2016

Colorectal Cancer - Pipeline by Loxo Oncology, Inc., H2 2016

Colorectal Cancer - Pipeline by Mabion SA, H2 2016

Colorectal Cancer - Pipeline by Mabtech Ltd, H2 2016

Colorectal Cancer - Pipeline by mAbxience SA, H2 2016

Colorectal Cancer - Pipeline by MacroGenics Inc, H2 2016

Colorectal Cancer - Pipeline by Marina Biotech Inc, H2 2016

Colorectal Cancer - Pipeline by MediaPharma srl, H2 2016

Colorectal Cancer - Pipeline by MedImmune LLC, H2 2016

Colorectal Cancer - Pipeline by Medinet Co Ltd, H2 2016

Colorectal Cancer - Pipeline by Merck & Co Inc, H2 2016

Colorectal Cancer - Pipeline by Merck KGaA, H2 2016

Colorectal Cancer - Pipeline by Merrimack Pharmaceuticals Inc, H2 2016

Colorectal Cancer - Pipeline by Merus NV, H2 2016

Colorectal Cancer - Pipeline by Microlin Bio, Inc., H2 2016

Colorectal Cancer - Pipeline by MolMed SpA, H2 2016

Colorectal Cancer - Pipeline by Mologen AG, H2 2016

Colorectal Cancer - Pipeline by Morphotek Inc, H2 2016

Colorectal Cancer - Pipeline by Multimmune GmbH, H2 2016

Colorectal Cancer - Pipeline by Mycenax Biotech Inc, H2 2016

Colorectal Cancer - Pipeline by Natco Pharma Ltd, H2 2016

Colorectal Cancer - Pipeline by NatureWise Biotech & Medicals Corp, H2 2016

Colorectal Cancer - Pipeline by Nektar Therapeutics, H2 2016

Colorectal Cancer - Pipeline by Neovacs SA, H2 2016

Colorectal Cancer - Pipeline by Nerviano Medical Sciences Srl, H2 2016

Colorectal Cancer - Pipeline by Nippon Kayaku Co Ltd, H2 2016

Colorectal Cancer - Pipeline by NormOxys Inc, H2 2016

Colorectal Cancer - Pipeline by Northwest Biotherapeutics Inc, H2 2016

Colorectal Cancer - Pipeline by Novartis AG, H2 2016

Colorectal Cancer - Pipeline by Novogen Ltd, H2 2016

Colorectal Cancer - Pipeline by Noxxon Pharma AG, H2 2016

Colorectal Cancer - Pipeline by NuCana BioMed Ltd, H2 2016

Colorectal Cancer - Pipeline by OBI Pharma Inc, H2 2016

Colorectal Cancer - Pipeline by Oncobiologics Inc, H2 2016

Colorectal Cancer - Pipeline by Oncolytics Biotech Inc, H2 2016

Colorectal Cancer - Pipeline by OncoMed Pharmaceuticals Inc, H2 2016

Colorectal Cancer - Pipeline by Onconova Therapeutics Inc, H2 2016

Colorectal Cancer - Pipeline by Ono Pharmaceutical Co Ltd, H2 2016

List of Figures:

Number of Products under Development for Colorectal Cancer, H2 2016

Number of Products under Development for Colorectal Cancer - Comparative Analysis, H2 2016

Number of Products under Development by Companies, H2 2016

Number of Products under Investigation by Universities/Institutes, H2 2016

Comparative Analysis by Late Stage Development, H2 2016

Comparative Analysis by Clinical Stage Development, H2 2016

Comparative Analysis by Early Stage Products, H2 2016

Assessment by Monotherapy Products, H2 2016

Assessment by Combination Products, H2 2016

Number of Products by Top 10 Targets, H2 2016

Number of Products by Stage and Top 10 Targets, H2 2016

Number of Products by Top 10 Mechanism of Actions, H2 2016

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016

Number of Products by Top 10 Routes of Administration, H2 2016

Number of Products by Stage and Top 10 Routes of Administration, H2 2016

Number of Products by Top 10 Molecule Types, H2 2016

Number of Products by Stage and Top 10 Molecule Types, H2
Note: Product cover images may vary from those shown
3 of 4
  • 2cureX ApS
  • 3-V Biosciences Inc
  • 3M Drug Delivery Systems
  • 3SBio Inc
  • 4SC AG
  • AB Science SA
  • AbbVie Inc
  • AbGenomics International Inc
  • Accelerated Pharma Inc
  • Adamed Sp z oo
  • Aduro BioTech Inc
  • Advenchen Laboratories LLC
  • Alchemia Ltd
  • Allinky Biopharma
  • Amal Therapeutics SA
  • amcure GmbH
  • Amgen Inc
  • Antibe Therapeutics Inc
  • Apac Biotech Pvt Ltd
  • Apexigen Inc
  • Aphios Corp
  • Aposense Ltd
  • Arisaph Pharmaceuticals Inc
  • ARMO Biosciences Inc
  • ArQule Inc
  • Array BioPharma Inc
  • Asana BioSciences LLC
  • Aslan Pharmaceuticals Pte Ltd
  • Astellas Pharma Inc
  • Astex Pharmaceuticals Inc
  • AstraZeneca Plc
  • ATLAB Pharma SAS
  • AVEO Pharmaceuticals Inc
  • B Cell Design SAS
  • Basilea Pharmaceutica Ltd
  • Bavarian Nordic A/S
  • Bayer AG
  • BeiGene Ltd
  • BeyondSpring Pharmaceuticals Inc
  • Biocon Ltd
  • Bionomics Ltd
  • Bionovis SA
  • Biotecnol Ltd
  • Biothera Pharmaceutical Inc
  • Boehringer Ingelheim GmbH
  • Boston Biomedical Inc
  • Bristol-Myers Squibb Company
  • Burzynski Research Institute Inc
  • Calithera Biosciences Inc
  • Cancer Prevention Pharmaceuticals Inc
  • Carna Biosciences Inc
  • Cascadian Therapeutics Inc
  • CBT Pharmaceuticals Inc
  • CCRP Therapeutics GmbH
  • Celgene Corp
  • Cellceutix Corp
  • Celldex Therapeutics Inc
  • Cellectar Biosciences Inc
  • Celltrion Inc
  • Celyad SA
  • Chiome Bioscience Inc
  • Chipscreen Biosciences Ltd
  • ChoDang Pharm Co Ltd
  • Cipla Ltd
  • Cleave Biosciences Inc
  • Cleveland BioLabs Inc
  • COARE Biotechnology Inc
  • Coherus BioSciences Inc
  • Compugen Ltd
  • Cornerstone Pharmaceuticals Inc
  • Corvus Pharmaceuticals Inc
  • Critical Outcome Technologies Inc
  • CrystalGenomics Inc
  • Cytune Pharma SAS
  • Daiichi Sankyo Company Ltd
  • DanDrit Biotech A/S
  • Deciphera Pharmaceuticals LLC
  • Dicerna Pharmaceuticals Inc
  • Double Bond Pharmaceutical International AB
  • Dr. Reddy's Laboratories Ltd
  • EirGenix Inc
  • Eisai Co Ltd
  • Eli Lilly and Company
  • Endor Nanotechnologies SL
  • enGene Inc
  • EnGeneIC Ltd
  • Ensol Biosciences Inc
  • EntreChem SL
  • Enzo Biochem Inc
  • Etubics Corp
  • Exelixis Inc
  • F. Hoffmann-La Roche Ltd
  • Five Prime Therapeutics Inc
  • Formosa Laboratories Inc
  • Fusion Antibodies Ltd
  • Gene Techno Science Co Ltd
  • Genentech Inc
  • Genor BioPharma Co Ltd
  • Genoscience Pharma
  • Genzyme Corp
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • Glycotope GmbH
  • Golden Biotechnology Corp
  • Green Cross Corp
  • Hadasit Medical Research Services & Development Ltd
  • Handok Inc
  • Hanmi Pharmaceuticals Co Ltd
  • Heat Biologics Inc
  • Hemispherx Biopharma Inc
  • Hutchison MediPharma Ltd
  • iDD biotech SAS
  • Ideaya Biosciences Inc
  • Ignyta Inc
  • Immodulon Therapeutics Ltd
  • ImmuneXcite Inc
  • Immunomedics Inc
  • Immunovative Therapies Ltd
  • Incanthera Ltd
  • Incyte Corp
  • Innovent Biologics Inc
  • Inovio Pharmaceuticals Inc
  • Interprotein Corp
  • Intezyne Technologies Inc
  • Ionis Pharmaceuticals Inc
  • IPD Therapeutics BV
  • Isofol Medical AB
  • Jeil Pharmaceutical Co Ltd
  • JHL Biotech Inc
  • Jiangsu Hengrui Medicine Co Ltd
  • Johnson & Johnson
  • KaloBios Pharmaceuticals Inc
  • Kancera AB
  • Karyopharm Therapeutics Inc
  • Kura Oncology Inc
  • Laboratorio ELEA SACIF y A
  • Lee's Pharmaceutical Holdings Ltd
  • Lion Biotechnologies Inc
  • LipoMedix Pharmaceutical Inc
  • Loxo Oncology, Inc.
  • Mabion SA
  • Mabtech Ltd
  • mAbxience SA
  • MacroGenics Inc
  • Marina Biotech Inc
  • MediaPharma srl
  • MedImmune LLC
  • Medinet Co Ltd
  • Merck & Co Inc
  • Merck KGaA
  • Merrimack Pharmaceuticals Inc
  • Merus NV
  • Microlin Bio, Inc.
  • MolMed SpA
  • Mologen AG
  • Morphotek Inc
  • Multimmune GmbH
  • Mycenax Biotech Inc
  • Natco Pharma Ltd
  • NatureWise Biotech & Medicals Corp
  • Nektar Therapeutics
  • Neovacs SA
  • Nerviano Medical Sciences Srl
  • Nippon Kayaku Co Ltd
  • NormOxys Inc
  • Northwest Biotherapeutics Inc
  • Novartis AG
  • Novogen Ltd
  • Noxxon Pharma AG
  • NuCana BioMed Ltd
  • OBI Pharma Inc
  • Oncobiologics Inc
  • Oncolytics Biotech Inc
  • OncoMed Pharmaceuticals Inc
  • Onconova Therapeutics Inc
  • Ono Pharmaceutical Co Ltd
  • Oryx GmbH & Co KG
  • Otsuka Holdings Co Ltd
  • Oxford BioMedica Plc
  • Pfizer Inc
  • Pharma Mar SA
  • PharmAbcine Inc
  • Pivot Pharmaceuticals Inc
  • Pivotal BioSciences Inc
  • PlantForm Corp
  • PLx Pharma Inc
  • Precision Biologics Inc
  • Prima BioMed Ltd
  • Propanc Health Group Corp
  • Provectus Biopharmaceuticals Inc
  • PsiOxus Therapeutics Ltd
  • Puma Biotechnology Inc
  • R Pharm
  • RedHill Biopharma Ltd
  • Redx Pharma Plc
  • Regeneron Pharmaceuticals Inc
  • Rexahn Pharmaceuticals Inc
  • Rgenix Inc
  • Rhizen Pharmaceuticals SA
  • Richter Gedeon Nyrt
  • Samumed LLC
  • Sanofi
  • Selvita SA
  • Shanghai Henlius Biotech Co Ltd
  • Shire Plc
  • Sigma-Tau SpA
  • Sigmoid Pharma Ltd
  • Sillajen Biotherapeutics
  • Solvotrin Therapeutics Ltd
  • Sorrento Therapeutics Inc
  • Sumitomo Dainippon Pharma Co Ltd
  • SuviCa Inc
  • Symphogen A/S
  • Synermore Biologics Co Ltd
  • Taiho Pharmaceutical Co Ltd
  • TaiwanJ Pharmaceuticals Co Ltd
  • Takeda Pharmaceutical Company Ltd
  • Tara Immuno-Oncology Therapeutics LLC
  • Targovax ASA
  • Tarveda Therapeutics Inc
  • Theravectys SA
  • Tiltan Pharma Ltd
  • Tocagen Inc
  • TRACON Pharmaceuticals Inc
  • Transgene SA
  • TyrNovo Ltd
  • United BioPharma Inc
  • Vaccinex Inc
  • VasGene Therapeutics Inc
  • Vaximm AG
  • Verastem Inc
  • Vertex Pharmaceuticals Inc
  • Viralytics Ltd
  • Wilex AG
  • WntResearch AB
  • XBiotech Inc
  • XuanZhu Pharma Co Ltd
  • Zymeworks Inc
Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll